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ORIGINAL ARTICLE
The transcobalamin (TCN2) 776C4G polymorphism
affects homocysteine concentrations among
subjects with low vitamin B12 status
A Stanis"awska-Sachadyn1,4, JV Woodside2, CM Sayers1, JW Yarnell2, IS Young2, AE Evans2,
LE Mitchell3 and AS Whitehead1
1Department of Pharmacology and Center for Pharmacogenetics, University of Pennsylvania School of Medicine, Philadelphia,
PA, USA; 2Cardiovascular Research Centre, Queen’s University Belfast, Belfast, Northern Ireland, UK and 3Human Genetics Center,
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Background/Objectives: Methionine synthase catalyzes the conversion of 5-methyltetrahydrofolate to tetrahydrofolate and
homocysteine (Hcy) to methionine using vitamin B12 as a cofactor. Transcobalamin is the main transporter of vitamin B12 from
blood into cells. This study was undertaken to assess the relationship between the transcobalamin P259R (TCN2 776C4G)
polymorphism and both serum vitamin B12 and total Hcy (tHcy) levels.
Subjects/Methods: The population comprised 613 men from Northern Ireland, aged 30–49 years, for whom tHcy, serum
vitamin B12 and serum folate concentrations were available. TCN2 776C4G genotypes were determined using a TaqMan
50 nuclease Real-Time PCR assay. Standard statistical tests of association were applied to assess the relationships between the
polymorphism and phenotypic variables.
Results: The TCN2 776CC homozygous genotype was associated with lower serum vitamin B12 concentrations compared with
the 776CG (Punadjusted¼0.01; Padjusted¼0.03) and 776GG genotypes (Punadjusted¼0.015; Padjusted¼0.045). Among individuals
with vitamin B12 concentrations in the lower half of the distribution, tHcy concentrations were higher in TCN2 776GG
homozygotes than in individuals with the other genotypes (Punadjusted¼ 0.015; Padjusted¼0.06).
Conclusions: These data suggest that, relative to transcobalamin with arginine at position 259 (776G), transcobalamin with
proline at this position (776C) is either more efficient at vitamin B12 transport from blood to tissues or has higher affinity for
vitamin B12. Furthermore, vitamin B12 status influences the relationship between TCN2 776C4G genotype and tHcy
concentrations. Thus, the TCN2 776C4G polymorphism may contribute to the risk of pathologies associated with a low B12,
and high tHcy phenotype.
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Introduction
Vitamin B12 (cobalamin) is an enzyme cofactor that is
synthesized only in microorganisms and, in humans, must
be obtained from food or supplements (Scott and Weir,
1994). Serum vitamin B12 concentrations decrease with age
(Baik and Russell, 1999), and among elderly patients with
clinically apparent vitamin B12 deficiency, 75–90% develop
neurological complications such as sensory and motor
disturbances and cognitive impairment (Baik and Russell,
1999). Low B12 status is associated with increased levels
of total homocysteine (tHcy) and methylmalonic acid
(Pennypacker et al., 1992), and low maternal B12 status in
early pregnancy has been associated with an increased risk of
spina bifida in the offspring (Kirke et al., 1993; Molloy et al.,
2009).
Vitamin B12 is transported from the intestine to the
bloodstream in a complex with intrinsic factor (Seetharam,
1999), whereas its transport from blood to cells depends
Received 28 February 2010; revised 14 May 2010; accepted 18 May 2010;
published online 1 September 2010
Correspondence: Professor AS Whitehead, Department of Pharmacology,
University of Pennsylvania School of Medicine, 153 Johnson Pavilion, 3620
Hamilton Walk, Philadelphia, PA 19104-6084, USA.
E-mail: aswhiteh@mail.med.upenn.edu
4Current address: Department of Biology and Genetics, Medical University of
Gdan´sk, De¸binki 1, 80-211 Gdan´sk, Poland.
European Journal of Clinical Nutrition (2010) 64, 1338–1343
& 2010 Macmillan Publishers Limited All rights reserved 0954-3007/10
www.nature.com/ejcn
mainly on transcobalamin (Seetharam et al., 1999). Inade-
quate cellular levels of vitamin B12 may be due to impairment
in either of these processes. Intracellular vitamin B12 is a
cofactor of methionine synthase, which catalyzes the
conversion of Hcy to methionine, concomitant with the
conversion of 5-methyl-tetrahydrofolate (5-methyl-THF) to
THF (Figure 1). Hence, altered levels of B12 may cause
changes in folate/Hcy metabolism (Selhub et al., 2007). It has
been suggested that the inhibition of methionine synthase
caused by B12 deficiency creates a ‘methyl-trap’, which
results in the accumulation of 5-methyl-THF and hence the
elevation of tHcy concentrations (Scott and Weir, 1981).
Transcobalamin is synthesized by hepatocytes, endothelial
cells and enterocytes (Ermens et al., 2003). Although most
circulating B12 is bound by haptocorrin, transcobalamin
binds 22–37% of plasma B12 (Refsum et al., 2006a), and
is responsible for up to 99% of B12 transport into tissues
(Baik and Russell, 1999). In humans the gene encoding
transcobalamin (TCN2) is polymorphic (Daiger et al., 1978).
To date, six nonsynonymous single nucleotide polymorph-
isms have been identified (Li et al., 1994; Afman et al., 2002),
the most extensively studied of which is TCN2 776C4G
(rs1801198) (P259R) in exon 6. Higher holo-transcobalamin
(transcobalamin–vitamin B12 complex) levels are observed
among TCN2 776CC homozygotes than in those with
the other TCN2 776C4G genotypes (Miller et al., 2002).
Furthermore, in the highest quartile of the vitamin B12
distribution, TCN2 776CC homozygotes have lower tHcy
concentrations compared with those with the other geno-
types (Lievers et al., 2002). The latter observation suggests
that plasma vitamin B12 levels are a determinant of the
relationship between TCN2 776C4G genotype and tHcy
concentrations. In addition, the TCN2 776GG genotype has
been associated with a lower proportion of vitamin B12 bound
to transcobalamin (calculated as a holo-transcobalamin/
total transcobalamin ratio) (Afman et al., 2002), lower holo-
transcobalamin levels per se (Afman et al., 2002; Wans et al.,
2003; von Castel-Dunwoody et al., 2005), lower apo-transco-
balamin (that is, transcobalamin not bound to vitamin B12)
levels (Namour et al., 1998, 2001), lower total transcobalamin
levels (Namour et al., 2001; Afman et al., 2002), higher
methylmalonic acid concentrations (Miller et al., 2002;
Fredriksen et al., 2007) and higher tHcy concentrations
(Alessio et al., 2007; Gueant et al., 2007). The association
between the TCN2 776C4G polymorphism and tHcy levels
has also been reported to be underpinned, in part, by folate
concentrations (Gueant et al., 2006). In epidemiological
studies, the TCN2 776C4G polymorphism has been
associated with the risk of several conditions including
Alzheimer’s disease (McCaddon et al., 2004), spontaneous
abortion (Zetterberg et al., 2002) and spina bifida (Pietrzyk
and Bik-Multanowski, 2003). However, the association with
Figure 1 Schematic representation of folate/Hcy metabolism, incorporating a model for potential phenotypic consequences of having
TC P259 (left) or TC R259 (right). CBS, cystathionine b-synthase; DHF, dihydrofolate; DHFR, dihydrofolate reductase; dTMP, deoxythymidine
monophosphate; dUMP deoxyuridine monophosphate; Hcy homocysteine; MTHFR, 5,10-methylenetetrahydrofolate reductase;
MTR, methionine synthase; SAH, S-adenosylhomocysteine; SAM, S-adenosylmethionine; SHMT, serine hydroxymethyltransferase; TC, transcobalamin;
THF, tetrahydrofolate; TYMS, thymidylate synthase.
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spina bifida has not been observed in all studies of this
condition (Afman et al., 2002; Swanson et al., 2005).
The aim of this study was to investigate the relationships
between the TCN2 776C4G genotype, vitamin B12, folate
and tHcy concentrations in a population of Northern
Irish men aged 30–49 years and to identify particular
genotype/phenotype combinations that might confer risk
of pathologies that are known to be associated with




The study population has been previously described
(Harmon et al., 1996; Woodside et al., 1998). Briefly, between
January and March 1995, 765 male volunteers aged 30–49
years, from a single Belfast-based industrial workforce, were
invited to a screening clinic. Men from all grades of staff
(that is, manual, clerical, administrative and executive) were
eligible to participate in the study. After giving informed
consent, a fasting venous blood sample was obtained from
each study subject and a brief medical history was taken; 140
individuals who were either diabetic, had been administered
a general anesthetic within the previous 3 months, or were
using vitamin supplements, were excluded. The study was
approved by the Research Ethics Committee of the Faculty of
Medicine, the Queen’s University of Belfast, in compliance
with the guidelines of the Royal College of Physicians of
London.
Genetic analysis
TCN2 776C4G (rs1801198) genotypes were determined
using a TaqMan 50 nuclease Real-Time PCR assay on a
PTC-200 DNA Engine (Bio-Rad, Hercules, CA, USA) with
fluorescence detection by a Chromo4 Real-Time PCR
detector (Bio-Rad). Individual PCR amplification reactions
(final volume of 20 ml each) contained 4–25ng of sample
DNA, 1 TaqMan Universal PCR Master Mix, No AmpErase
UNG (Applied Biosystems, Foster City, CA, USA), 0.5 mM
forward primer (50-TCTATCACCAGTTCCTCATGA-30) and
0.5 mM reverse primer (50-GCCTTGAGACATGCTGTTC-30),
50nM C-specific probe (VIC-CCCCAGGCATGGG) and
50nM G-specific probe (FAM-CCCCACGCATGGG). Probe
sequences were derived from the SNP500Cancer website
(http://snp500cancer.nci.nih.gov). The probes were synthe-
sized by Applied Biosystems. For the PCR amplification,
initial incubation was at 95 1C for 10min followed by
60 cycles of denaturation at 95 1C for 30 s and extension/50
nuclease steps at 62 1C for 40 s. Dual fluorescence was
detected after each completed 70 s cycle. Genotypes
were assigned using Opticon Monitor 3 analysis software
(Bio-Rad).
Determination of tHcy, serum vitamin B12 and serum folate
concentrations
The methods for determining tHcy (that is, free plus protein-
bound Hcy), serum vitamin B12 and serum folate have
previously been described (Harmon et al., 1996). In brief, tHcy
was quantified using the modified high-performance liquid
chromatography method (Ubbink et al., 1991). Serum vitamin
B12 and serum folate concentrations were ascertained using a
kit from ICN Pharmaceuticals (Costa Mesa, CA, USA).
Statistical methods
Descriptive analyses of the study variables were conducted
using data from all study subjects, and included means,
medians and percentiles for continuous variables (that is,
tHcy, serum vitamin B12 and serum folate) and proportions
for categorical variables (that is, genotypes). In addition,
departure of the TCN2 776C4G genotype distribution from
Hardy–Weinberg equilibrium was assessed using w2 analysis.
The distributions of tHcy, serum vitamin B12 and serum
folate were skewed, even after log transformation. Therefore,
non-parametric and ranked analyses were performed. Differ-
ences in tHcy, vitamin B12 and serum folate concentrations
between the TCN2 776C4G genotypes in the population as
a whole and within strata defined by vitamin B12 and folate
levels were tested using the Kruskal–Wallis test. Tests with
associated P-values p0.05 were followed by pairwise com-
parisons using Wilcoxon rank-sum tests, corrected for
multiple comparisons using Bonferroni method. Adjusted
P-values of p0.05 were considered statistically significant.
All statistical analyses were carried out using SAS version 9.1
(SAS Institute Inc., Cary, NC, USA).
Results
A total of 625 men participated in this study. However,
biochemical and genetic data were unavailable for 10
subjects. In addition, two subjects had extreme tHcy
concentrations of 58.5 and 76.9 mmol/l and were excluded,
leaving data from 613 subjects for analysis. The charac-
teristics of the study subjects are summarized in Table 1. The
distribution of TCN2 776C4G genotypes was not signi-
ficantly different than expected under the assumption of
Hardy–Weinberg equilibrium (P¼0.2).
In the whole population, serum vitamin B12 concentrations
were significantly associated with the TCN2 776C4G genotype
(P¼0.01), with significantly lower B12 concentrations among
TCN2 776CC homozygotes, as compared to those with the
TCN2 776CG (Punadjusted¼0.01; Padjusted¼0.03) or GG geno-
types (Punadjusted¼ 0.015; Padjusted¼0.045) (Table 2). In contrast,
tHcy levels were not significantly related to TCN2 776C4G
genotype in the total study population (P¼ 0.4, Table 2).
However, following subdivision of the study population into
those with B12 concentrations at or below the median
(p261.96pmol/l) and above the median (4261.96pmol/l),
TCN2 polymorphism, vitamin B12 and homocysteine
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an association between the TCN2 776C4G genotype and tHcy
concentration was observed in the former (Table 2). In this
subset, TCN2 776GG homozygotes had higher median tHcy
concentration compared with 776C allele carriers (8.5 vs
7.5mmol/l; Punadjusted¼0.015). However, after Bonferroni
adjustment for the four comparisons, this observation was no
longer significant (Padjusted¼0.06). No such association was
observed among subjects with B12 levels above the median.
Furthermore, the TCN2 776C4G polymorphism was not
associated with altered serum folate concentrations in any of
the subgroups defined by vitamin B12 levels (data not shown).
When the study population was analyzed after sub-
division according to folate concentrations, that is, at or
below the median (p10.81nmol/l) and above the median
(410.81nmol/l), there was no significant association
between the TCN2 776C4G genotype and tHcy concentra-
tion in either subgroup (data not shown). Further, when the
study population was analyzed after subdivision according
to a combination of folate and vitamin B12 concentrations
(that is, folate p10.81nmol/l and B12 p261.96pmol/l; folate
410.81nmol/l and B12 4261.96pmol/l; folate p10.81nmol/l
and B12 4261.96pmol/l; folate 410.81nmol/l and B12
p261.96pmol/l;), there was no significant association between
the TCN2 776C4G genotype and tHcy concentration in any
of the subgroups (data not shown).
Discussion
In our Northern Irish male study population, the TCN2
776C4G (P259R) genotype is associated with serum vitamin
B12 concentrations, the 776CC genotype being associated
with lower concentrations compared with those with other
genotypes. Other investigators have reported that the TCN2
776C4G polymorphism shows no association with altered
vitamin B12 concentrations in several heterogeneous popula-
tions (Miller et al., 2002; Wans et al., 2003; Zetterberg et al.,
2003; von Castel-Dunwoody et al., 2005; Alessio et al., 2007;
Fredriksen et al., 2007). However, in two of these populations
(Miller et al., 2002; Fredriksen et al., 2007), the TCN2
776C4G polymorphism was associated with altered con-
centrations of methylmalonic acid, a good indicator of
cellular vitamin B12 status. Our observations therefore may
indicate that the different transcobalamin variants differen-
tially affect the distribution of vitamin B12 between the
circulation and tissues such that there is less circulating
vitamin B12 in TCN2 776CC homozygotes than in 776CG
heterozygotes or 776GG homozygotes.
Recently, the two-domain structure of transcobalamin,
comprising an N-terminal domain of 12 a-helices plus a 3/10
helix and a C-terminal domain with mostly b-strands,
was solved by X-ray crystallography (Wuerges et al., 2006).
The polymorphic site at amino-acid residue 259 is located in
the N-terminal domain in the turn preceding helix a11. Any
change in the properties of this turn could alter the tertiary
Table 2 Associations between TCN2 776 C4G genotype and biochemical parameters in the population as a whole and in subsets after stratification
by vitamin B12 concentration
a
Biochemical parameter TCN2 776CC TCN2 776CG TCN2 776GG P-value by
Kruskal–Wallis
All subjects
Homocysteine (mmol/l) 7.2 (5.8–8.9) (195) 6.9 (5.9–8.4) (286) 7.2 (5.9–8.6) (132) 0.4





Homocysteine (mmol/l) 7.5 (6.1–9.4) (108) 7.4 (6.2–8.9) (132) 8.5 (6.5–10.9) (58) 0.04c
4261.96 pmol/l
highest 50%
6.6 (5.5–8.4) (82) 6.5 (5.4–7.6) (144) 6.6 (5.6–7.5) (73) 0.6
Abbreviation: TCN2, transcobalamin gene.
aMedian (25th–75th percentile) (n, number of individuals).
bPunadjusted¼0.015 for comparison of TCN2 776CC with GG; Punadjusted¼0.01 for comparison of TCN2 776CC with CG; and Punadjusted¼0.5 for comparison of TCN2
776CG with GG genotype.
cPunadjusted¼ 0.05 for comparison of TCN2 776CC with GG; Punadjusted¼0.5 for comparison of TCN2 776CC with CG; Punadjusted¼0.01 for comparison of TCN2
776CG with GG; and Punadjusted¼ 0.015 for comparison of TCN2 776C allele with GG genotype.
Table 1 Characteristics of male industrial workers in Belfast, Northern
Ireland




613 7.5 (±2.8) 7.1 (5.9–8.6)
B12 (pmol/l)
a 597 279.8 (±112.5) 262.7 (202.8–344.1)





Abbreviation: TCN2, transcobalamin gene.
aVitamin B12 levels were not known for 16 subjects.
bSerum folate levels were not known for 15 subjects.
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positions of the flanking a-helices and ultimately affect the
overall structure of the protein and its vitamin B12-binding
capability. That the substitution at residue 259 is a proline,
known as a helix breaker, increases the likelihood that the
two forms of the transporter specified by TCN2 776C4G are
functionally distinct. Indeed, it has been suggested by
others that transcobalamin P259R variants may exhibit
different vitamin B12-binding affinities (Afman et al., 2002;
Miller et al., 2002). Another mechanism by which the TCN2
776C4G polymorphism might affect vitamin B12 distribu-
tion is suggested by the reported differences in 776C and
776G transcript concentrations (Namour et al., 2001).
Our data indicate that the TCN2 776C4G genotype is also
associated with tHcy concentrations in subjects in the lower
half of the vitamin B12 distribution; TCN2 776GG homo-
zygotes in this subset have higher tHcy concentrations than
776C allele carriers (Punadjusted¼0.015; Padjusted¼0.06). The
apparently paradoxical observation of high circulating
vitamin B12 (in the population as a whole) and high tHcy
concentrations (in the lower half of the B12 distribution)
associated with the TCN2 776G allele may be the result of
less efficient vitamin B12 transport from the circulation to
tissue and a consequent biased distribution of the available
pool of B12 favoring retention in the circulation. With
respect to remethylation of Hcy to methionine, the reduced
levels of tissue B12 in TCN2 776GG homozygotes may
become biologically relevant when overall B12 status is
suboptimal. A possible mechanism for the observed associa-
tion between the TCN2 776C4G polymorphism and tHcy is
suggested by the ‘methyl-trap’ hypothesis (Scott and Weir
1981). According to this hypothesis, when inadequate
amounts of cellular vitamin B12 are available, Hcy levels
increase due to impairment of the activity of methionine
synthase, which requires vitamin B12 as a cofactor (Figure 1).
Less efficient vitamin B12 transport into the tissues of TCN2
776GG homozygotes may therefore result in increased
tHcy concentrations among individuals who have low
serum vitamin B12 levels. Under this scenario, a genetically
mandated reciprocal relationship with tHcy would not be
apparent among subjects with high serum vitamin B12 status
and consequent optimally active methionine synthase.
However, we were unable to test this possible explanation
in our study population as cellular 5-methyl-THF concentra-
tions were not available.
In conclusion, we report that in a study population of
613 Northern Irish men, the TCN2 776C4G genotype is
associated with circulating vitamin B12 concentrations. This
is most likely attributable to higher vitamin B12 transport
from blood to tissues associated with the transporter
encoded by the TCN2 776C allele (which results in a proline
at residue 259 in the amino-acid sequence) than that
associated with the transporter encoded by the TCN2 776G
allele (which results in an arginine at residue 259). However,
biochemical and biological studies of the relative transfer
efficiencies and B12 affinities of the transcobalamin variants
will be needed in order to define the precise mechanism
underlying the above observation. After subdivision of the
study population according to serum vitamin B12 status, the
776GG genotype (carried by 21.5% of subjects in our study
population) was associated with elevated tHcy concentra-
tions among subjects in the lower half of the B12 distri-
bution, although this finding will need to be confirmed in
a larger study. The above observations suggest that the TCN2
776GG genotype may be a modest risk factor for lower
cellular vitamin B12 levels and concomitantly elevated tHcy
concentrations. This genotype may therefore contribute to
the risk of pathologies such as cardiovascular disease that
have been associated with a low folate, low B12, and high
tHcy phenotype (Selhub 2006; Refsum et al., 2006b).
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